Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05827523 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)

Study acronym: FOCUS / KOV-04
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 1 to 10
    • Study title expanded, about 3 words
    v6
  2. Study title shortened, about 1 wordv5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 30, 2023 to May 31, 2023
    • Site details revised
    v4
  4. Re-verified, no change to tracked fieldsv3
  5. Secondary endpoints: details revised at 3 of 8 entriesv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Primary stage III-IV epithelial ovarian cancer randomizing between interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC)
Trial Details
NCT Number NCT05827523
Lead Sponsor National Cancer Center, Korea
Conditions
(from sponsor)		 Ovarian Cancer
Related terms Carcinoma, Ovarian Epithelial, Ovarian Neoplasms
Enrollment 520 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov